SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher ...

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

By Brooke Hudspeth, Pharm.D. University of Kentucky You’ve likely heard about glucagon-like peptide-1 agonists – usually ...

GLP-1 receptor agonists like semaglutide and the dual GIP/GLP-1 agonist tirzepatide mimic naturally occurring hormones that regulate blood sugar, appetite, and digestion. GLP-1 (glucagon-like ...

The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health ...

Semaglutide and similar peptide drugs bind the G-protein coupled GLP-1 receptor to transfer chemical signals from outside the ...

In 2025, Släcka introduces a functional beverage designed to combat mid-afternoon cravings by offering a healthier ...

Insurance companies are increasingly restricting coverage for GLP-1 medications, impacting patient access and affordability.

A large study of over 185,000 adults with type 2 diabetes found that GLP-1 receptor agonist use was linked to a slight increase in new diabetic retinopathy cases but fewer severe eye complications, ...

The company is also focused on strategic capital deployment. It has already invested in GLP-1 drug substance and drug product ...

Weight-loss drugs like Mounjaro and Ozempic work wonders on your waistline but can cause chaos with your scalp. Here’s what ...

The two GLP-1 makers have also begun to offer discounts to users who pay in cash directly. These programs, which cost about $500 per month, may require the use of a vial and syringe, as opposed to ...